Antibody-mediated phagocytosis contributes to the anti-tumor activity of the therapeutic antibody daratumumab in lymphoma and multiple myelomaMarije B. Overdijk, Paul W.H.I. Parren|mAbs|2015Cited by 502
DuoHexaBody-CD37®, a novel biparatopic CD37 antibody with enhanced Fc-mediated hexamerization as a potential therapy for B-cell malignanciesSimone C. Oostindie, Esther C.W. Breij, Laurens P. Kil et al.|Blood Cancer Journal|2020Cited by 70